,3,4 In the case of patients with DMD/BMD, diverse methods for causative mutation investigation have been employed, of which multiplex ligation-dependent probe amplification (MLPA) is commonly and preferentially applied to simultaneously screen all 79 exons of DMD for deletions/duplications.5 This evidence concerns the gene DMD and Duchenne muscular dystrophy.